About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in Austin | 13,060 Studies Near You | Clareo Health

Clinical Trials LocationsAustin

Clinical Trials in Austin

Discover 13,060 clinical trials near Austin, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 11441-11460 of 13,060 trials

COMPLETEDPhase 3< 1 mile

Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia

NCT00095719

The purpose of this trial is to test the safety \& tolerability of intramuscular aripiprazole in acutely agitated patients diagnosed with Dementia.

DementiaAlzheimer's Disease

Otsuka Pharmaceutical Development & Commercialization, Inc.125 participantsStarted Dec 2003

Santa Ana, California, United States • Hamden, Connecticut, United States • Hialeah, Florida, United States +11 more locations

COMPLETEDPhase 3< 1 mile

Aripiprazole in Patients With Acute Mania

NCT00095511

The purpose of this trial is to test the safety \& efficacy of aripiprazole in patients with Bipolar Mania for a period of at least 12 weeks.

Bipolar Disorder

Otsuka Pharmaceutical Development & Commercialization, Inc.615 participantsStarted Jun 2004

Tuscaloosa, Alabama, United States • Scottsdale, Arizona, United States • Cerritos, California, United States +35 more locations

Find Trials by Condition in Austin

Breast Cancerin Austin Lung Cancerin Austin Prostate Cancerin Austin Colorectal Cancerin Austin Melanomain Austin Leukemiain Austin Lymphomain Austin Pancreatic Cancerin Austin Ovarian Cancerin Austin Brain Cancerin Austin Diabetesin Austin

Data from ClinicalTrials.govTerms

COMPLETEDPhase 3< 1 mile

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

NCT00095524

The primary purpose of this study is to compare the affects of aripiprazole and olanzapine on weight change.

Body Weight ChangeSchizophreniaSchizoaffective Disorder+1 more

Otsuka Pharmaceutical Development & Commercialization, Inc.300 participantsStarted Mar 2004

Little Rock, Arkansas, United States • Anaheim, California, United States • Cerritos, California, United States +29 more locations

COMPLETEDPhase 3< 1 mile

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

NCT00095745

This trial is a 52-week safety study to evaluate the safety of adjunctive aripiprazole in outpatients with major depressive disorder who have experienced an incomplete response to an ongoing antidepressant trial.

Major Depressive Disorder

Otsuka Pharmaceutical Development & Commercialization, Inc.1,002 participantsStarted Sep 2004

Mesa, Arizona, United States • Peoria, Arizona, United States • Beverly Hills, California, United States +55 more locations

COMPLETEDPhase 274 miles

A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)

NCT00028353

If you are a male 30 years of age or older and have a positive diagnosis of high grade (II or III) prostate Intraepithelial Neoplasia (PIN) or have had an abnormal/suspicious prostate biopsy, you may be eligible for this study. This is a study of an investigational medication that may reduce high grade PIN and prevent the occurrence of prostate cancer. This study is currently enrolling up to 500 men at approximately 60 locations in the United States.

Prostatic Intraepithelial Neoplasia

GTx500 participantsStarted Apr 2001

Huntsville, Alabama, United States • Little Rock, Arkansas, United States • Aventura, Florida, United States +22 more locations

COMPLETEDPhase 274 miles

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

NCT00600821

To determine if the addition of AG-013736 to chemotherapy is beneficial in patients with advanced lung cancer who have not been previously treated.

Non-Small-Cell Lung CarcinomaAdenocarcinoma

Pfizer118 participantsStarted Apr 2008

Baton Rouge, Louisiana, United States • Pittsfield, Massachusetts, United States • Columbus, Mississippi, United States +41 more locations

COMPLETEDPhase 1/280 miles

Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

NCT00002577

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy in treating patients with non-small cell lung cancer that cannot be surgically removed.

Radiation Therapy Oncology Group36 participantsStarted Jul 1995

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Huntsville, Alabama, United States +239 more locations

COMPLETEDPhase 280 miles

Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer

NCT00003591

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy plus paclitaxel in treating patients who have nonmetastatic, unresectable pancreatic cancer.

Pancreatic Cancer

Radiation Therapy Oncology Group122 participantsStarted Nov 1998

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +231 more locations

COMPLETEDPhase 3147 miles

An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence

NCT00080470

This clinical trial is being conducted to investigate the safety and effectiveness of a new device designed to treat urinary urge incontinence in those patients who have tried and failed two or more conservative therapies.

Urinary Incontinence

Boston Scientific Corporation148 participantsStarted Jun 2003

Tucson, Arizona, United States • Stanford, California, United States • Englewood, Colorado, United States +8 more locations

COMPLETEDNA147 miles

Effects of a Vitality Dietary Supplement on Physical and Mental Function in Middle-aged Adults

NCT01155076

The purpose of the study is to determine the effects of 8 weeks Vitality Product supplementation on physical and mental function in middle-aged adults

Health-related Quality of Life

Pharmanex116 participantsStarted Jul 2010

Tucson, Arizona, United States • Chaska, Minnesota, United States • Houston, Texas, United States

COMPLETEDPhase 1147 miles

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B

NCT01590641

Dose cohorts may be dosed with one of up to 4 possible total weekly doses (0.3 mg, 1 mg, 2 mg, 4 mg). Dose escalation or repetition will be governed by pre-specified safety and activity rules. Subjects will be confined on either days 1-3 or days 1-3 and 8-10. Follow-up visits are also required periodically through day 43, and potential viral load follow-up visits at weeks 3 and 6 months post last dose. Study procedures involve blood draws for pharmacokinetic, pharmacodynamic, virologic, and safety assessments

Gilead Sciences49 participantsStarted Apr 2012

Phoenix, Arizona, United States • Costa Mesa, California, United States • San Diego, California, United States +20 more locations

COMPLETED147 miles

Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)

NCT00617019

The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.

Parkinson Disease

Boehringer Ingelheim3,234 participantsStarted Sep 2006

Gilbert, Arizona, United States • Scottsdale, Arizona, United States • Sun City, Arizona, United States +46 more locations

COMPLETEDPhase 3147 miles

A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

NCT00094432

The purpose of this study is to evaluate several doses of aripiprazole in patients with bipolar depression.

Bipolar I Disorder

Otsuka Pharmaceutical Development & Commercialization, Inc.650 participantsStarted Jun 2004

Mesa, Arizona, United States • La Mesa, California, United States • La Palma, California, United States +37 more locations

UNKNOWNPhase 2147 miles

Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

NCT00003634

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. It is not yet known whether giving monoclonal antibody therapy is more effective than a placebo in treating patients with ovarian epithelial, fallopian tube, or peritoneal cancer who have responded to surgery and chemotherapy. PURPOSE: Randomized phase II trial to study the effectiveness of monoclonal antibody therapy in treating patients with residual disease from stage III or stage IV ovarian epithelial, fallopian tube, or peritoneal cancer following surgery and chemotherapy.

Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer

AltaRex400 participantsStarted Apr 1998

Berkeley, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +43 more locations

COMPLETEDPhase 3169 miles

Study of Aripiprazole in Patients With Acute Bipolar Mania

NCT00097266

The purpose of this research study is to confirm the safety and effectiveness of aripiprazole therapy over 12 weeks in subjects with bipolar disorder experiencing symptoms of mania.

Bipolar Disorder

Otsuka Pharmaceutical Development & Commercialization, Inc.615 participantsStarted Dec 2004

Anaheim, California, United States • Cerritos, California, United States • Garden Grove, California, United States +42 more locations

COMPLETEDPhase 2172 miles

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

NCT00828841

This study is testing the investigational drug, cetuximab, in combination with different chemotherapy drugs for lung cancer. The aim of the study is to determine which of the drug combinations looks most promising and should be tested further. The study will also look at what side effects may occur.

Non-Small Cell Lung Cancer

Accelerated Community Oncology Research Network601 participantsStarted Dec 2008

Anniston, Alabama, United States • Jonesboro, Arkansas, United States • Anaheim, California, United States +81 more locations

COMPLETEDPhase 3360 miles

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

NCT00046384

The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with acute symptoms of Bipolar Disorder.

Bipolar I Disorder

Otsuka Pharmaceutical Development & Commercialization, Inc.Started Jun 2002

Scottsdale, Arizona, United States • Little Rock, Arkansas, United States • Chula Vista, California, United States +11 more locations

UNKNOWNPhase 2360 miles

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

NCT00036998

RATIONALE: Microwave thermotherapy kills tumor cells by heating them to several degrees above body temperature. PURPOSE: Randomized phase II trial to compare the effectiveness of microwave thermotherapy before surgery to that of surgery alone in treating women who have stage I or stage II breast cancer.

ImunonStarted Aug 2001

Los Angeles, California, United States • Orange, California, United States • Coral Springs, Florida, United States +5 more locations

TERMINATEDPhase 2419 miles

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

NCT00003292

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of ifosfamide in treating patients with meningeal tumors that have recurred or that cannot be removed surgically.

ChondrosarcomaAdult FibrosarcomaAdult Leiomyosarcoma+3 more

SWOG Cancer Research Network7 participantsStarted Jul 1998

Scottsdale, Arizona, United States • Duarte, California, United States • Palo Alto, California, United States +67 more locations

COMPLETEDPhase 3454 miles

Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® Soft

NCT00877279

This study is to determine the safety and effectiveness of Belotero® Soft compared to active comparator in the correction of mild facial wrinkles, such as nasolabial folds.

Facial Wrinkles

Merz North America, Inc.64 participantsStarted Nov 2007

Los Angeles, California, United States • San Francisco, California, United States • New Haven, Connecticut, United States +2 more locations

PreviousPage 573 of 653Next

Heart Diseasein Austin